TCBPTC BioPharm (Holdings) plc

Nasdaq tcbiopharm.com


$ 6.03 $ -0.20 (-3.21 %)    

Thursday, 12-Sep-2024 11:06:14 EDT
QQQ $ 470.44 $ 1.81 (0.39 %)
DIA $ 408.77 $ -0.69 (-0.17 %)
SPY $ 555.43 $ 0.45 (0.08 %)
TLT $ 100.02 $ -0.35 (-0.35 %)
GLD $ 235.87 $ 1.23 (0.52 %)
$ 5.32
$ 6.24
-- x --
$ 6.00 x 162
$ 6.25 - $ 6.25
$ 2.11 - $ 1,139.40
209,289
na
52.62M
$ -16,376.81
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tcbp-announces-first-patient-completed-the-full-dose-regimen-in-achieve-clinical-trial

No TCB008-related Adverse Events seen in any of the re-start patients6 Patients received second dose, 3 Patients received third...

 tc-biopharm-closes-public-offering-of-2m-adss-and-series-g-warrants-at-1-per-ads

Warrants Priced At £0.78 Per ADS, Expiring In One Year

 why-tc-biopharm-tcbp-stock-is-down-40

TC BioPharm shares are trading lower by 44% Wednesday morning. The company announced the pricing of an offering of 2 million un...

 tc-biopharm-has-been-granted-european-patent-number-ep3283620-titled-modified-gamma-delta-cells-and-uses-thereof-for-the-treatment-of-cancer-or-infectious-diseases

https://register.epo.org/application?number=EP16721208 

 tcbp-launches-compassionate-use-program-for-tcb008

The Company's lead therapeutic will be available through a newly opened compassionate use programEDINBURGH, Scotland, May 1...

 tc-biopharm-announces-exercise-of-warrants-for-31-million-gross-proceeds

TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology compa...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION